CompletedNot Applicable

Electrolysis Percutaneous Therapeutic (EPTE) for Supraspinatus Tendinopathy

Spain36 participantsStarted 2014-07

Plain-language summary

Therapeutic management of supraspinatus tendinopathy is conflicting. There is evidence that eccentric exercise protocols can be effective for this condition. The inclusion of other therapeutic modalities could help to the management of these patients. A new therapeutic approach, called Electrolysis Percutaneous Therapeutic (EPTE) has been clinically developed. The objective of this randomized clinical trial is to determine the effectiveness of the inclusion of EPTE into a eccentric exercise protocol for the management of patients with unilateral supraspinatus tendinopathy

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Unilateral supraspinatus tendinopathy * Shoulder pain from at least 3 months * Shoulder pain of more than 4 points on a NPRS * Positive findings of supraspinatus tendinopathy on MRI Exclusion Criteria: * bilateral shoulder symptoms * younger than 18 or older than 65 years * history of shoulder fractures or dislocation * cervical radiculopathy * previous interventions with steroid injections * fibromyalgia syndrome * previous history of shoulder or neck surgery * any type of intervention for the neck-shoulder area during the previous year

What they're measuring

Changes in pain intensity before and after the intervention

Timeframe: Baseline, after 2 weeks of treatment and one week after the last session

Trial details

NCT IDNCT02196948

SponsorUniversidad Rey Juan Carlos

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-12

View on ClinicalTrials.gov More Supraspinatus Tendinopathy trials